{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:16:32Z","timestamp":1773018992557,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T00:00:00Z","timestamp":1348531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s40291-012-0004-5","type":"journal-article","created":{"date-parts":[[2012,9,24]],"date-time":"2012-09-24T05:15:20Z","timestamp":1348463720000},"page":"303-309","source":"Crossref","is-referenced-by-count":23,"title":["Influence of an Interaction between Lithium Salts and a Functional Polymorphism in SLC1A2 on the History of Illness in Bipolar Disorder"],"prefix":"10.1007","volume":"16","author":[{"given":"Sara","family":"Dallaspezia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Poletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Lorenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele","family":"Pirovano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,25]]},"reference":[{"issue":"1","key":"4_CR1","first-page":"5","volume":"56","author":"DA Solomon","year":"1995","unstructured":"Solomon DA, Keitner GI, Miller IW, Shea MT, Keller MB. Course of illness and maintenance treatments for patients with bipolar disorder. J Clin Psychiatry. 1995;56(1):5\u201313.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"4_CR2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1600-0447.1993.tb03434.x","volume":"88","author":"A Deister","year":"1993","unstructured":"Deister A, Marneros A. Predicting the long-term outcome of affective disorders. Acta Psychiatr Scand. 1993;88(3):174\u20137.","journal-title":"Acta Psychiatr Scand"},{"issue":"11","key":"4_CR3","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1176\/ajp.152.11.1635","volume":"152","author":"MJ Gitlin","year":"1995","unstructured":"Gitlin MJ, Swendsen J, Heller TL, Hammen C. Relapse and impairment in bipolar disorder. Am J Psychiatry. 1995;152(11):1635\u201340.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"4_CR4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jad.2011.04.055","volume":"133","author":"AM Nivoli","year":"2011","unstructured":"Nivoli AM, Pacchiarotti I, Rosa AR, Popovic D, Murru A, Valenti M, et al. Gender differences in a cohort study of 604 bipolar patients: the role of predominant polarity. J Affect Disord. 2011;133(3):443\u20139.","journal-title":"J Affect Disord"},{"issue":"1","key":"4_CR5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2004.11.022","volume":"376","author":"F Benedetti","year":"2005","unstructured":"Benedetti F, Serretti A, Pontiggia A, Bernasconi A, Lorenzi C, Colombo C, et al. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-\u03b2 \u221250 T\/C SNP. Neurosci Lett. 2005;376(1):51\u20135.","journal-title":"Neurosci Lett"},{"issue":"1","key":"4_CR6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tins.2011.11.009","volume":"35","author":"RJ Schloesser","year":"2012","unstructured":"Schloesser RJ, Martinowich K, Manji HK. Mood-stabilizing drugs: mechanisms of action. Trends Neurosci. 2012;35(1):36\u201346.","journal-title":"Trends Neurosci"},{"issue":"10","key":"4_CR7","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/jcp.22609","volume":"226","author":"K Kim","year":"2011","unstructured":"Kim K, Lee SG, Kegelman TP, Su ZZ, Das SK, Dash R, et al. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J Cell Physiol. 2011;226(10):2484\u201393.","journal-title":"J Cell Physiol"},{"issue":"1","key":"4_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","volume":"65","author":"NC Danbolt","year":"2001","unstructured":"Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001;65(1):1\u2013105.","journal-title":"Prog Neurobiol"},{"issue":"3","key":"4_CR9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0896-6273(00)80086-0","volume":"16","author":"JD Rothstein","year":"1996","unstructured":"Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron. 1996;16(3):675\u201386.","journal-title":"Neuron"},{"issue":"1\u20132","key":"4_CR10","first-page":"63","volume":"136","author":"JS Rao","year":"2012","unstructured":"Rao JS, Kellom M, Reese EA, Rapoport SI, Kim HW. Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. J Affect Disord. 2012;136(1\u20132):63\u201371.","journal-title":"J Affect Disord"},{"issue":"3","key":"4_CR11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00001756-199702100-00039","volume":"8","author":"T Meyer","year":"1997","unstructured":"Meyer T, Ludolph AC, Morkel M, Hagemeier C, Speer A. Genomic organization of the human excitatory amino acid transporter gene GLT-1. Neuroreport. 1997;8(3):775\u20137.","journal-title":"Neuroreport"},{"issue":"3","key":"4_CR12","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20051979","volume":"203","author":"J Mallolas","year":"2006","unstructured":"Mallolas J, Hurtado O, Castellanos M, Blanco M, Sobrino T, Serena J, et al. A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke. J Exp Med. 2006;203(3):711\u20137.","journal-title":"J Exp Med"},{"issue":"1\u20132","key":"4_CR13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jneuroim.2008.01.011","volume":"195","author":"O Pampliega","year":"2008","unstructured":"Pampliega O, Domercq M, Villoslada P, Sepulcre J, Rodriguez-Antiguedad A, Matute C. Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis. J Neuroimmunol. 2008;195(1\u20132):194\u20138.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"4_CR14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2007.09.015","volume":"427","author":"Y Matsumoto","year":"2007","unstructured":"Matsumoto Y, Suzuki A, Ishii G, Oshino S, Otani K, Goto K. The \u2212181 A\/C polymorphism in the excitatory amino acid transporter-2 gene promoter affects the personality trait of reward dependence in healthy subjects. Neurosci Lett. 2007;427(2):99\u2013102.","journal-title":"Neurosci Lett"},{"issue":"Suppl. 1","key":"4_CR15","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/sj.mp.4001021","volume":"7","author":"JH Krystal","year":"2002","unstructured":"Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry. 2002;7(Suppl. 1):S71\u201380.","journal-title":"Mol Psychiatry"},{"issue":"7","key":"4_CR16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archpsyc.61.7.705","volume":"61","author":"G Sanacora","year":"2004","unstructured":"Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, et al. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry. 2004;61(7):705\u201313.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"4_CR17","first-page":"136","volume":"2","author":"HK Manji","year":"2003","unstructured":"Manji HK, Quiroz JA, Payne JL, Singh J, Lopes BP, Viegas JS, et al. The underlying neurobiology of bipolar disorder. World Psychiatry. 2003;2(3):136\u201346.","journal-title":"World Psychiatry"},{"issue":"11","key":"4_CR18","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","volume":"62","author":"K Hashimoto","year":"2007","unstructured":"Hashimoto K, Sawa A, Iyo M. Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry. 2007;62(11):1310\u20136.","journal-title":"Biol Psychiatry"},{"issue":"1\u20132","key":"4_CR19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00213-003-1756-8","volume":"173","author":"J Singh","year":"2004","unstructured":"Singh J, Zarate CA Jr, Krystal AD. Case report: successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine. Psychopharmacology. 2004;173(1\u20132):227\u20138.","journal-title":"Psychopharmacology"},{"issue":"4","key":"4_CR20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.biopsych.2004.11.023","volume":"57","author":"CA Zarate Jr","year":"2005","unstructured":"Zarate CA Jr, Quiroz JA, Singh JB, Denicoff KD, De Jesus G, Luckenbaugh DA, et al. An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol Psychiatry. 2005;57(4):430\u20132.","journal-title":"Biol Psychiatry"},{"issue":"8","key":"4_CR21","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1997","unstructured":"Moghaddam B, Adams B, Verma A, Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci. 1997;17(8):2921\u20137.","journal-title":"J Neurosci"},{"issue":"2","key":"4_CR22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pharmthera.2009.02.010","volume":"123","author":"R Machado-Vieira","year":"2009","unstructured":"Machado-Vieira R, Salvadore G, Diazgranados N, Zarate CA Jr. Ketamine and the next generation of antidepressants with a rapid onset of action. Pharmacol Ther. 2009;123(2):143\u201350.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"4_CR23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1034\/j.1399-5618.2002.02235.x","volume":"4","author":"KM Cecil","year":"2002","unstructured":"Cecil KM, DelBello MP, Morey R, Strakowski SM. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disord. 2002;4(6):357\u201365.","journal-title":"Bipolar Disord"},{"issue":"5","key":"4_CR24","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archpsyc.61.5.450","volume":"61","author":"SR Dager","year":"2004","unstructured":"Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK, et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry. 2004;61(5):450\u20138.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"4_CR25","first-page":"832","volume":"21","author":"M Castillo","year":"2000","unstructured":"Castillo M, Kwock L, Courvoisie H, Hooper SR. Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations. AJNR Am J Neuroradiol. 2000;21(5):832\u20138.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"4_CR26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pscychresns.2008.08.004","volume":"173","author":"F Benedetti","year":"2009","unstructured":"Benedetti F, Calabrese G, Bernasconi A, Cadioli M, Colombo C, Dallaspezia S, et al. Spectroscopic correlates of antidepressant response to sleep deprivation and light therapy: a 3.0 Tesla study of bipolar depression. Psychiatry Res. 2009;173(3):238\u201342.","journal-title":"Psychiatry Res"},{"issue":"4","key":"4_CR27","first-page":"297","volume":"13","author":"S Dalvie","year":"2010","unstructured":"Dalvie S, Horn N, Nossek C, van der Merwe L, Stein DJ, Ramesar R. Psychosis and relapse in bipolar disorder are related to GRM3, DAOA, and GRIN2B genotype. Afr J Psychiatry (Johannesbg). 2010;13(4):297\u2013301.","journal-title":"Afr J Psychiatry (Johannesbg)"},{"issue":"8","key":"4_CR28","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archpsyc.1982.04290080001001","volume":"39","author":"JF Leckman","year":"1982","unstructured":"Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM. Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry. 1982;39(8):879\u201383.","journal-title":"Arch Gen Psychiatry"},{"key":"4_CR29","volume-title":"Generalized, linear, and mixed models","author":"CE McCulloch","year":"2008","unstructured":"McCulloch CE, Searle SR, Neuhaus JM. Generalized, linear, and mixed models. 2nd ed. New York: Wiley; 2008.","edition":"2"},{"key":"4_CR30","volume-title":"Univariate and multivariate general linear models: theory and applications with SAS","author":"K Kim","year":"2007","unstructured":"Kim K, Timm N. Univariate and multivariate general linear models: theory and applications with SAS. 2nd ed. New York: Chapman and Hall; 2007.","edition":"2"},{"key":"4_CR31","first-page":"245","volume-title":"Statistics: methods and applications. A comprehensive reference for science, industry, and data mining","author":"T Hill","year":"2006","unstructured":"Hill T, Lewicki P. General linear models. In: Hill T, Lewicki P, editors. Statistics: methods and applications. A comprehensive reference for science, industry, and data mining. Tulsa: StatSoft; 2006. p. 245\u201376."},{"key":"4_CR32","unstructured":"Bruhn H, Stoppe G, Staedt J, Merboldt KD, Hanicke W, Frahm J. Quantitative proton MRS in vivo shows cerebral myo-inositol and cholines to be unchanged in manic-depressive patients treated with lithium [abstract]. In: Proceedings of the Society of Magnetic Resonance in Medicine: Twelfth Annual Scientific Meeting; 1993 Aug 14\u201320; New York."},{"issue":"3","key":"4_CR33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00213-003-1440-z","volume":"168","author":"N Michael","year":"2003","unstructured":"Michael N, Erfurth A, Ohrmann P, Gossling M, Arolt V, Heindel W, et al. Acute mania is accompanied by elevated glutamate\/glutamine levels within the left dorsolateral prefrontal cortex. Psychopharmacology. 2003;168(3):344\u20136.","journal-title":"Psychopharmacology"},{"issue":"6","key":"4_CR34","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.pnpbp.2006.03.012","volume":"30","author":"A Yildiz-Yesiloglu","year":"2006","unstructured":"Yildiz-Yesiloglu A, Ankerst DP. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(6):969\u201395.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"4_CR35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.mp.4001585","volume":"10","author":"SM Strakowski","year":"2005","unstructured":"Strakowski SM, Delbello MP, Adler CM. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatry. 2005;10(1):105\u201316.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"4_CR36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.biopsych.2004.06.021","volume":"56","author":"C McDonald","year":"2004","unstructured":"McDonald C, Zanelli J, Rabe-Hesketh S, Ellison-Wright I, Sham P, Kalidindi S, et al. Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol Psychiatry. 2004;56(6):411\u20137.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"4_CR37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1399-5618.2006.00284.x","volume":"8","author":"IK Lyoo","year":"2006","unstructured":"Lyoo IK, Sung YH, Dager SR, Friedman SD, Lee JY, Kim SJ, et al. Regional cerebral cortical thinning in bipolar disorder. Bipolar Disord. 2006;8(1):65\u201374.","journal-title":"Bipolar Disord"},{"issue":"4","key":"4_CR38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/1073858403252773","volume":"9","author":"G Rajkowska","year":"2003","unstructured":"Rajkowska G. Depression: what we can learn from postmortem studies. Neuroscientist. 2003;9(4):273\u201384.","journal-title":"Neuroscientist"},{"issue":"4","key":"4_CR39","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/mp.2009.47","volume":"15","author":"JS Rao","year":"2010","unstructured":"Rao JS, Harry GJ, Rapoport SI, Kim HW. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry. 2010;15(4):384\u201392.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"4_CR40","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1517\/14728220902926127","volume":"13","author":"L Bunch","year":"2009","unstructured":"Bunch L, Erichsen MN, Jensen AA. Excitatory amino acid transporters as potential drug targets. Expert Opin Ther Targets. 2009;13(6):719\u201331.","journal-title":"Expert Opin Ther Targets"},{"issue":"5","key":"4_CR41","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.biopsych.2004.06.012","volume":"56","author":"SD Friedman","year":"2004","unstructured":"Friedman SD, Dager SR, Parow A, Hirashima F, Demopulos C, Stoll AL, et al. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biol Psychiatry. 2004;56(5):340\u20138.","journal-title":"Biol Psychiatry"},{"issue":"6","key":"4_CR42","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/sj.mp.4002151","volume":"13","author":"P Sklar","year":"2008","unstructured":"Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, et al. Whole-genome association study of bipolar disorder. Mol Psychiatry. 2008;13(6):558\u201369.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"4_CR43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1523\/JNEUROSCI.3080-07.2008","volume":"28","author":"J Du","year":"2008","unstructured":"Du J, Creson TK, Wu LJ, Ren M, Gray NA, Falke C, et al. The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior. J Neurosci. 2008;28(1):68\u201379.","journal-title":"J Neurosci"},{"key":"4_CR44","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/386824a0","volume":"38","author":"WC Drevets","year":"1997","unstructured":"Drevets WC, Price JL, Simpson JRJ, Todd RD, Reich T, Vannier M, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 1997;38:824\u20137.","journal-title":"Nature"},{"issue":"8","key":"4_CR45","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0006-3223(00)00950-1","volume":"48","author":"G Rajkowska","year":"2000","unstructured":"Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry. 2000;48(8):766\u201377.","journal-title":"Biol Psychiatry"},{"key":"4_CR46","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0006-3223(99)00165-1","volume":"46","author":"HK Manji","year":"1999","unstructured":"Manji HK, Moore GJ, Chen G. Lithium at 50: have the neuroprotective effects of this unique cation been overlooked. Biol Psychiatry. 1999;46:929\u201340.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"4_CR47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2007.09.074","volume":"429","author":"ES Monkul","year":"2007","unstructured":"Monkul ES, Matsuo K, Nicoletti MA, Dierschke N, Hatch JP, Dalwani M, et al. Prefrontal gray matter increases in healthy individuals after lithium treatment: a voxel-based morphometry study. Neurosci Lett. 2007;429(1):7\u201311.","journal-title":"Neurosci Lett"},{"issue":"11","key":"4_CR48","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.biopsych.2010.01.020","volume":"67","author":"E Bora","year":"2010","unstructured":"Bora E, Fornito A, Yucel M, Pantelis C. Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biol Psychiatry. 2010;67(11):1097\u2013105.","journal-title":"Biol Psychiatry"},{"issue":"1\u20133","key":"4_CR49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jad.2011.07.006","volume":"135","author":"F Benedetti","year":"2011","unstructured":"Benedetti F, Radaelli D, Poletti S, Locatelli C, Falini A, Colombo C, et al. Opposite effects of suicidality and lithium on gray matter volumes in bipolar depression. J Affect Disord. 2011;135(1\u20133):139\u201347.","journal-title":"J Affect Disord"},{"issue":"8","key":"4_CR50","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/npp.2010.41","volume":"35","author":"IK Lyoo","year":"2010","unstructured":"Lyoo IK, Dager SR, Kim JE, Yoon SJ, Friedman SD, Dunner DL, et al. Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. Neuropsychopharmacology. 2010;35(8):1743\u201350.","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"4_CR51","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4088\/JCP.07m03745","volume":"70","author":"GJ Moore","year":"2009","unstructured":"Moore GJ, Cortese BM, Glitz DA, Zajac-Benitez C, Quiroz JA, Uhde TW, et al. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J Clin Psychiatry. 2009;70(5):699\u2013705.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"4_CR52","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.neuroscience.2009.04.013","volume":"161","author":"N Sourial-Bassillious","year":"2009","unstructured":"Sourial-Bassillious N, Rydelius PA, Aperia A, Aizman O. Glutamate-mediated calcium signaling: a potential target for lithium action. Neuroscience. 2009;161(4):1126\u201334.","journal-title":"Neuroscience"},{"issue":"Pt 20","key":"4_CR53","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1113\/jphysiol.2010.195115","volume":"588","author":"C Gebhardt","year":"2010","unstructured":"Gebhardt C, Cull-Candy SG. Lithium acts as a potentiator of AMPAR currents in hippocampal CA1 cells by selectively increasing channel open probability. J Physiol. 2010;588(Pt 20):3933\u201341.","journal-title":"J Physiol"},{"issue":"4","key":"4_CR54","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","volume":"63","author":"S Maeng","year":"2008","unstructured":"Maeng S, Zarate CA Jr, Du J, Schloesser RJ, McCammon J, Chen G, et al. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry. 2008;63(4):349\u201352.","journal-title":"Biol Psychiatry"},{"issue":"17","key":"4_CR55","doi-asserted-by":"crossref","first-page":"9890","DOI":"10.1074\/jbc.270.17.9890","volume":"270","author":"D Trotti","year":"1995","unstructured":"Trotti D, Volterra A, Lehre KP, Rossi D, Gjesdal O, Racagni G, et al. Arachidonic acid inhibits a purified and reconstituted glutamate transporter directly from the water phase and not via the phospholipid membrane. J Biol Chem. 1995;270(17):9890\u20135.","journal-title":"J Biol Chem"},{"issue":"12","key":"4_CR56","doi-asserted-by":"crossref","first-page":"6433","DOI":"10.1074\/jbc.270.12.6433","volume":"270","author":"N Zerangue","year":"1995","unstructured":"Zerangue N, Arriza JL, Amara SG, Kavanaugh MP. Differential modulation of human glutamate transporter subtypes by arachidonic acid. J Biol Chem. 1995;270(12):6433\u20135.","journal-title":"J Biol Chem"},{"issue":"5","key":"4_CR57","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1046\/j.1471-4159.2001.00349.x","volume":"77","author":"B Hassel","year":"2001","unstructured":"Hassel B, Iversen EG, Gjerstad L, Tauboll E. Up-regulation of hippocampal glutamate transport during chronic treatment with sodium valproate. J Neurochem. 2001;77(5):1285\u201392.","journal-title":"J Neurochem"},{"issue":"2","key":"4_CR58","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1176\/appi.ajp.2008.08030322","volume":"166","author":"MA Frye","year":"2009","unstructured":"Frye MA, Helleman G, McElroy SL, Altshuler LL, Black DO, Keck PE Jr, et al. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry. 2009;166(2):164\u201372.","journal-title":"Am J Psychiatry"},{"issue":"9","key":"4_CR59","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.4088\/JCP.08m04811yel","volume":"71","author":"RM Post","year":"2010","unstructured":"Post RM, Altshuler LL, Frye MA, Suppes T, Keck PE Jr, McElroy SL, et al. Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. J Clin Psychiatry. 2010;71(9):1176\u201386. quiz 1252\u20131253.","journal-title":"J Clin Psychiatry"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-012-0004-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40291-012-0004-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-012-0004-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:49:56Z","timestamp":1562201396000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40291-012-0004-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,25]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["4"],"URL":"https:\/\/doi.org\/10.1007\/s40291-012-0004-5","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,25]]}}}